Literature DB >> 18304570

Improvement of drug tolerance in immunogenicity testing by acid treatment on Biacore.

Denise Sickert1, Kerstin Kroeger, Christophe Zickler, Edwige Chokote, Barbara Winkler, Jean-Michel Grenet, Francois Legay, Annette Zaar.   

Abstract

Detection of anti-drug antibodies (ADA) can be difficult, if not impossible, in the presence of drug in the sample. This is a particular concern with therapeutic monoclonal antibodies (mAbs), which have typically longer half-lives than other proteins. For detection of ADA in presence of high drug concentrations, assay choice is limited to ELISA-like methods, capable of incorporating acid dissociation procedures to separate drug-ADA immune complexes. To our knowledge, Biacore assays have not been shown to be directly compatible with acid dissociation procedures, until now. As a consequence, steps to ensure adequate clearance of the drug are prerequisite to enable sensitive detection of ADA. Here we describe the development of a novel, rapid and highly drug tolerant Biacore method that uses an acid dissociation step to detect ADA in the presence of excess drug in human serum. Removal of drug after acid treatment is not required.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18304570     DOI: 10.1016/j.jim.2008.01.010

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  10 in total

1.  Ligand binding assays in the 21st Century laboratory: platforms.

Authors:  Franklin P Spriggs; Zhandong Don Zhong; Afshin Safavi; Darshana Jani; Narasaiah Dontha; Anita Kant; Jenny Ly; Lia Brilando; Karolina Österlund; Nathalie Rouleau; Saloumeh Kadkhodayan Fischer; Martin Boissonneault; Chad Ray
Journal:  AAPS J       Date:  2012-03       Impact factor: 4.009

2.  A survey of applications of biological products for drug interference of immunogenicity assays.

Authors:  Yow-Ming C Wang; Lanyan Fang; Lin Zhou; Jie Wang; Hae-Young Ahn
Journal:  Pharm Res       Date:  2012-08-18       Impact factor: 4.200

Review 3.  Theoretical considerations and practical approaches to address the effect of anti-drug antibody (ADA) on quantification of biotherapeutics in circulation.

Authors:  Marian Kelley; Ago B Ahene; Boris Gorovits; John Kamerud; Lindsay E King; Thomas McIntosh; Jihong Yang
Journal:  AAPS J       Date:  2013-03-30       Impact factor: 4.009

4.  Drug Target Interference in Immunogenicity Assays: Recommendations and Mitigation Strategies.

Authors:  Zhandong Don Zhong; Adrienne Clements-Egan; Boris Gorovits; Mauricio Maia; Giane Sumner; Valerie Theobald; Yuling Wu; Manoj Rajadhyaksha
Journal:  AAPS J       Date:  2017-10-23       Impact factor: 4.009

5.  Practical application of acid dissociation in monitoring patients treated with adalimumab.

Authors:  Francisca Llinares-Tello; José Rosas-Gómez de Salazar; José Miguel Senabre-Gallego; Gregorio Santos-Soler; Carlos Santos-Ramírez; Esteban Salas-Heredia; Xavier Barber-Vallés; Juan Molina-García
Journal:  Rheumatol Int       Date:  2014-05-10       Impact factor: 2.631

6.  Evaluation of Multiple Immunoassay Technology Platforms to Select the Anti-Drug Antibody Assay Exhibiting the Most Appropriate Drug and Target Tolerance.

Authors:  Justine Collet-Brose; Pierre-Jean Couble; Maureen R Deehan; Robert J Nelson; Walter G Ferlin; Sabrina Lory
Journal:  J Immunol Res       Date:  2016-05-03       Impact factor: 4.818

Review 7.  Emerging Technologies and Generic Assays for the Detection of Anti-Drug Antibodies.

Authors:  Michael A Partridge; Shobha Purushothama; Chinnasamy Elango; Yanmei Lu
Journal:  J Immunol Res       Date:  2016-07-31       Impact factor: 4.818

8.  A Surface Plasmon Resonance-based assay to measure serum concentrations of therapeutic antibodies and anti-drug antibodies.

Authors:  Marten Beeg; Alessandro Nobili; Barbara Orsini; Francesca Rogai; Daniela Gilardi; Gionata Fiorino; Silvio Danese; Mario Salmona; Silvio Garattini; Marco Gobbi
Journal:  Sci Rep       Date:  2019-02-14       Impact factor: 4.379

9.  Assessment of immunogenicity and drug activity in patient sera by flow-induced dispersion analysis.

Authors:  Morten E Pedersen; Jesper Østergaard; Bente Glintborg; Merete L Hetland; Henrik Jensen
Journal:  Sci Rep       Date:  2022-03-18       Impact factor: 4.379

Review 10.  Assessing the Immunogenicity of Biopharmaceuticals.

Authors:  Carlos Pineda; Gilberto Castañeda Hernández; Ira A Jacobs; Daniel F Alvarez; Claudio Carini
Journal:  BioDrugs       Date:  2016-06       Impact factor: 5.807

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.